ENvue Medical, Inc. (FEED) intrinsic value & 10-year financials
ENvue Medical, Inc. (FEED) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 30.7% a year to $2.6M, with an average return on invested capital of 451.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.37
- Market cap
- $233.2K
- Revenue (FY2025)
- $2.6M
- Revenue growth (10-yr CAGR)
- 30.7%
- ROIC (10-yr avg)
- 451.5%
- Free cash flow (FY2025)
- -$9.4M
FEED 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.6M | -$18.2M | -$26.69 | -$9.4M | -896.6% | -154.0% |
| FY2024 | $2.6M | -$3.7M | -$13.73 | -$2.5M | -140.0% | 5872.1% |
| FY2023 | $2.3M | -$3.7M | -$2.12 | -$3.6M | -150.5% | -95.2% |
| FY2022 | $752.0K | -$5.4M | -$3.84 | -$7.0M | -666.5% | -105.0% |
| FY2021 | $1.7M | -$14.3M | — | -$4.4M | -335.3% | 120.1% |
| FY2020 | $623.0K | -$4.3M | — | -$3.4M | -757.5% | 99.8% |
| FY2019 | $530.0K | -$5.8M | — | — | -971.9% | -567.2% |
| FY2018 | $318.0K | -$4.2M | — | -$3.6M | -1353.1% | -203.8% |
| FY2017 | $239.0K | -$5.0M | — | — | -1293.3% | -544.7% |
| FY2016 | $229.0K | -$2.8M | — | -$1.5M | -1011.4% | 92.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ENvue Medical, Inc. is a consistent compounder, expanding top-line revenue at 30.7% annually over the past decade.
ENvue Medical, Inc. has earned high returns on invested capital, averaging 15.6% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
ENvue Medical, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ENvue Medical, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-886.53 per share.